When did gemtesa come out?

When was Gemtesa first approved (and what does “came out” usually mean)?

“Gemtesa” (vibegron) came out in the sense of U.S. regulatory approval on April 26, 2018, when it received approval from the FDA for an overactive bladder indication.[1]

When did patients actually start getting it?

After FDA approval, availability typically followed commercial launch timelines, but the specific date of the first U.S. sales/launch isn’t provided in the sources used here. The clearest “came out” date is the FDA approval date.[1]

How does this compare with other overactive bladder drugs?

Gemtesa’s key milestone is the 2018 FDA approval date.[1] If you’re comparing launch timing to competitors (like Myrbetriq or Vesicare), you’d look at their respective FDA approval dates and subsequent market entry.

Source

1. DrugPatentWatch.com – Gemtesa (vibegron) approval/timeline reference